Internal Medicine, Cardiovascular Disease · Southaven, MS
NPI
1689651036
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
391 Southcrest Cir, Ste. 200
Southaven, MS, 38671
Phone (901) 271-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$535K
16,283 services
Medicare patients, 2024
3,237
Average age 75
Drug cost, 2024
$4.1M
21,183 prescriptions
Company payments, 2025
$334K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dharmesh S Patel was code 99214 (office e&m - established), 2,488 times for 1,686 patients. In total Dharmesh S Patel billed 16,283 services in 74 codes, and Medicare paid $535K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,488 | 1,686 | $80.75 | $201K |
| 36415 Venipuncture Blood Collection | Office | 1,687 | 1,207 | $8.57 | $14K |
| 93000 Electrocardiogram | Office | 1,588 | 1,343 | $8.89 | $14K |
| 80053 Clinical Chemistry | Office | 1,085 | 923 | $10.32 | $11K |
| 80061 Clinical Chemistry | Office | 931 | 814 | $13.10 | $12K |
| 93306 Echocardiography (TTE/TEE) | Office | 760 | 750 | $51.47 | $39K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 743 | 717 | $25.78 | $19K |
| 83880 Clinical Chemistry | Office | 495 | 395 | $38.07 | $19K |
| 93016 Electrocardiogram | Office | 485 | 484 | $14.13 | $6,853 |
| 93018 Electrocardiogram | Office | 485 | 484 | $9.36 | $4,537 |
| 78452 Myocardial Perfusion Scan | Office | 462 | 462 | $51.70 | $24K |
| 85610 Clinical Chemistry | Office | 443 | 40 | $4.20 | $1,861 |
| 85025 Blood Count | Office | 440 | 409 | $7.58 | $3,336 |
| 93793 Care Management/Coordination | Office | 417 | 37 | $7.13 | $2,972 |
| 99457 E&M - Miscellaneous | Office | 417 | 56 | $33.01 | $14K |
By year: 2022 $608K for 20,781 services; 2023 $617K for 25,786 services; 2024 $535K for 16,283 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,687 | 1,207 | $8.57 | $14K |
| 80053 Clinical Chemistry | 1,085 | 923 | $10.32 | $11K |
| 80061 Clinical Chemistry | 931 | 814 | $13.10 | $12K |
| 83880 Clinical Chemistry | 495 | 395 | $38.07 | $19K |
| 85610 Clinical Chemistry | 443 | 40 | $4.20 | $1,861 |
| 85025 Blood Count | 440 | 409 | $7.58 | $3,336 |
| 84443 Clinical Chemistry | 338 | 320 | $16.42 | $5,550 |
| 80048 Clinical Chemistry | 271 | 207 | $8.21 | $2,226 |
| 83036 Blood Count | 154 | 150 | $9.52 | $1,466 |
| 83735 Clinical Chemistry | 55 | 54 | $6.57 | $361 |
Medicare prescription drug claims, 2024
In 2024, the drug Dharmesh S Patel prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,705 prescriptions and refills. In total Dharmesh S Patel wrote 21,183 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,705 | 4,250 | 619 | $18K |
| Ezetimibe Generic | 1,471 | 3,502 | 528 | $30K |
| Xarelto Rivaroxaban | 1,243 | 2,102 | 319 | $1.2M |
| Furosemide Generic | 969 | 1,998 | 330 | $3,968 |
| Carvedilol Generic | 929 | 2,168 | 298 | $6,194 |
| Amlodipine Besylate Generic | 902 | 2,266 | 334 | $4,919 |
| Atorvastatin Calcium Generic | 850 | 2,200 | 312 | $7,131 |
| Metoprolol Succinate Generic | 841 | 2,036 | 298 | $8,784 |
| Entresto Sacubitril/Valsartan | 603 | 967 | 156 | $601K |
| Losartan Potassium Generic | 600 | 1,451 | 208 | $6,140 |
| Repatha Sureclick Evolocumab | 597 | 769 | 118 | $425K |
| Potassium Chloride Generic | 558 | 1,021 | 176 | $7,820 |
| Jardiance Empagliflozin | 524 | 921 | 167 | $529K |
| Hydralazine Hcl Generic | 522 | 1,146 | 167 | $5,855 |
| Spironolactone Generic | 519 | 1,247 | 184 | $3,446 |
Brand drugs: 4,664 claims; generic drugs: 16,519 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dharmesh S Patel $334K ($334K in general payments such as food, travel and fees) from 27 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $108K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 99 | $108K |
| Amgen Inc. AMGN | 106 | $78K |
| Novo Nordisk Inc NVO | 31 | $64K |
| Lilly USA, LLC LLY | 43 | $40K |
| Medtronic, Inc. MDT | 31 | $14K |
| Ionis Pharmaceuticals, Inc. IONS | 15 | $11K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $7,924 |
| Merck Sharp & Dohme LLC MRK | 10 | $3,744 |
| Regeneron Pharmaceuticals, Inc. REGN | 4 | $3,572 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $2,385 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.